• The company intimated a scheduled Investor/Analyst meeting under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
  • The event is a group meeting format as part of the Investec Healthcare Roadtrip.
  • Date: June 3, 2026 (no specific time mentioned)
  • Location: New Jersey, United States of America
  • Format: In-person meeting
  • The stated purpose is investor/analyst engagement as part of a roadshow.
  • The company explicitly stated that discussions during the meeting will be based solely on publicly available information.
  • No management participants or their designations were specified in the disclosure.
  • No indication was provided about availability of presentation decks, transcripts, or recordings.

Additional Notes Section

  • The disclosure includes a compliance statement regarding the nature of information to be shared (publicly available only).
  • The company acknowledged a delay in filing this intimation, attributing it to the meeting being confirmed at short notice.
  • The information has been made available on the company's website: https://www.indegene.com/
  • No financial data, performance figures, or strategic updates were disclosed in this announcement.
  • The letter was digitally signed by Srishti Ramesh Kaushik, Company Secretary and Compliance Officer.